Fortress Biotech, Inc. (NASDAQ:FBIOP) Short Interest Up 97.9% in April

Fortress Biotech, Inc. (NASDAQ:FBIOP) saw a large increase in short interest in April. As of April 15th, there was short interest totalling 9,500 shares, an increase of 97.9% from the March 31st total of 4,800 shares. Based on an average daily trading volume, of 12,800 shares, the days-to-cover ratio is currently 0.7 days.

Fortress Biotech Stock Performance

Shares of NASDAQ FBIOP traded up $0.52 during mid-day trading on Friday, reaching $13.82. 4,596 shares of the company’s stock were exchanged, compared to its average volume of 13,002. The company’s 50-day moving average is $15.90 and its 200-day moving average is $13.56. Fortress Biotech has a 52-week low of $6.40 and a 52-week high of $18.91.

Fortress Biotech Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Tuesday, April 30th. Stockholders of record on Monday, April 15th will be given a dividend of $0.1953 per share. This represents a $2.34 annualized dividend and a dividend yield of 16.96%. The ex-dividend date of this dividend is Friday, April 12th.

About Fortress Biotech

Fortress Biotech, Inc, a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino an oral minocycline drug for the treatment of moderate to severe acne; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Exelderm cream for antifungal intended for topical use; Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Amzeeq; Zilxi; and Accutane capsules for severe recalcitrant nodular acne.